combined and used at the following final concentrations: AC4 hybridoma culture supernatant (monoclonal antibody recognizing SSEA-1), 1: 1; antibody to SSEA-I, 1:200; polyclonal rabbit antibodies against TH and DBH (Eugene Tech International, Inc., Allendale, NJ), 1:60. Secondary antibodies (fluorescein-and rhodamine-conjugated affinity-purified goat antibodies to rabbit immunoglobulins and goat antibodies to mouse gamma globulins; Organon Teknika, Malvern, PA) were added together as well at a final concentration of 1:10. 
that glycine may be absolutely required for NMDA-gated channels to open; the small current observed in the absence of added glycine could be due to nanomolar levels of contaminating glycine typically found in physiological solutions (6, 7) . Interest in these problems has sparked a search for antagonists of the glycine potentiation site (9) . I report that I2CA (Fig. 1 ) and several active derivatives competitively inhibit the action of glycine on the NMDA receptor.
Current elicited by NMDA was recorded in primary cultures of the rat visual cortex or spinal cord (10) with the whole-cell configuration of the patch-clamp technique (11, 12). In agreement with earlier work (6-8), glycine produced a dose-dependent increase in whole-cell current evoked by NMDA (Fig. 2) . At -70 mV, NMDA activated only a few picoamperes of current in the absence of added glycine (see below); saturating concentrations of glycine potentiated the response to NMDA by 5 to 100 times. The dose-response relation for glycine can be fitted well by the equation for one-to-one binding (Fig. 2C) (7, 8) , which suggests that the physiological response to glycine is directly proportional to receptor occupancy. I2CA and several active derivatives competitively antagonized the potentiation by glycine, causing a shift in the dose-response relation to higher glycine concentrations The dose dependence of antagonism can be fitted fairly well by a one-to-one binding curve (Fig. 3) . The IC50 values presented in Table 1 indicate significantly higher affinities for derivatives with fluorine or chlorine in the 5 position than for native I2CA or for 5-methyl-I2CA; the 5-methoxy derivative has much lower affinity and 5-hydroxy-I2CA is without effect at concentrations up to 1 mM (15). A number of other related compounds, pyrrole-2-carboxylic acid, indoline-2-carboxylic acid, quinaldic acid, picolinic acid, quinoxaline-2-carboxylic acid, and DL-pipecolic acid, were tested and had no effect (at 1 mM).
The active derivatives of I2CA are specific for the glycine potentiation site on the NMDA receptor. At 1 mM, there is no effect on CE-current elicited in spinal cord neurons by activation of strychnine-sensitive glycine receptors (16) and only minimal antagonism at non-NMDA receptors (17). Furthermore, I2CA does not interact with the NMDA binding site. The dose-response relation for NMDA with a high level of glycine (50 FLM) was not affected by the addition of 1 mM 5-F-I2CA (Fig. 4A) . Decreasing the amount of added glycine to 300 nM reduced the maximum response to NMDA but did not change the level of NMDA required for half-maximal activation (Fig. 4A) . This result confirms previous reports (6-8) and strongly suggests that glycine acts by directly increasing the probability of channel opening and not by chang- Table 1 . Inhibition of whole-cell current evoked by 30 FLM NMDA plus 300 nM added glycine. Dose-response experiments were performed as in Fig. 3 . IC50 values, presented as mean ? SEM of determinations, were obtained from the leastsquares fit of 1/(1 + [drug]/IC50) to each set of six drug concentrations (see Fig. 3, inset) ing the receptor's affinity for NMDA. Kleckner and Dingledine (7) have proposed that glycine is absolutely required for channel activation by NMDA, on the basis of studies in Xenopus oocytes injected with rat brain mRNA. My results indicate that glycine is also absolutely required when the channels are expressed by central nervous system neurons. In the presence of either zero or 300 nM added glycine, 5-F-I2CA (1 mM) completely blocked the current evoked by all concentrations of NMDA (Fig. 4, A   1 and B), which suggests that NMDA alone is not sufficient to open the channel. Indeed, at early times in culture, NMDA elicited very little current unless glycine was added (Fig.  4A) . By 6 to 10 days in vitro, however, the response to rapid perfusion of NMDA in solutions lacking glycine was often a substantial fraction of the maximal current obtained with glycine added (Fig. 4A) . This change over time in culture probably reflects the continual release of glycine by glial cells (6) that proliferate to confluence during the first week in vitro. Johnson and Ascher (6) have shown that medium conditioned by cultures contains significant levels of glycine; rapid perfusion apparently can reduce but not eliminate this contamination.
These experiments demonstrate that I2CA selectively and competitively inhibits the potentiating action of glycine on current elicited by NMDA. Together with recent results on another antagonist, 7-chlorokynurenic acid (9), they strengthen the proposal (7) that glycine is Iessential for channel activation (although it cannot be ruled out that I2CA may act as an inverse agonist at the glycine site). A number of studies have implicated NMDA receptors in the control of synaptic plasticity (2) and in excitotoxic cell death (18). Investigations of antagonists of the glycine potentiation site, such as I2CA, should lead to a better understanding of glycine's role in these processes; these antagonists may have therapeutic value for the treatment of stroke, epilepsy, and other neurodegenerative disorders (18).
